Compounds of the following formula (I):
##STR1##
where a, b, R1, R2, R3, R4 and
R6 are described herein, are useful as inhibitors of platelet adenosine
diphosphate. Pharmaceutical compositions containing these compounds, methods of
using these compounds as antithrombotic agents and processes for synthesizing these
compounds are also described herein.
